SE397974B - Forfarande for framstellning av 3-(trisubstituerad bensoyl)-propionsyra - Google Patents

Forfarande for framstellning av 3-(trisubstituerad bensoyl)-propionsyra

Info

Publication number
SE397974B
SE397974B SE7211766A SE1176672A SE397974B SE 397974 B SE397974 B SE 397974B SE 7211766 A SE7211766 A SE 7211766A SE 1176672 A SE1176672 A SE 1176672A SE 397974 B SE397974 B SE 397974B
Authority
SE
Sweden
Prior art keywords
prophic
tri
preparing
procedure
acid
Prior art date
Application number
SE7211766A
Other languages
English (en)
Inventor
T Murata
A Nohara
H Sugihara
Y Sanno
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP7108771A external-priority patent/JPS5233107B2/ja
Priority claimed from JP7108871A external-priority patent/JPS5233108B2/ja
Priority claimed from JP316772A external-priority patent/JPS5233109B2/ja
Priority claimed from JP540172A external-priority patent/JPS5233623B2/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of SE397974B publication Critical patent/SE397974B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/90Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7211766A 1971-09-13 1972-09-12 Forfarande for framstellning av 3-(trisubstituerad bensoyl)-propionsyra SE397974B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP7108771A JPS5233107B2 (sv) 1971-09-13 1971-09-13
JP7108871A JPS5233108B2 (sv) 1971-09-13 1971-09-13
JP316772A JPS5233109B2 (sv) 1971-12-29 1971-12-29
JP540172A JPS5233623B2 (sv) 1972-01-11 1972-01-11

Publications (1)

Publication Number Publication Date
SE397974B true SE397974B (sv) 1977-11-28

Family

ID=27453803

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7211766A SE397974B (sv) 1971-09-13 1972-09-12 Forfarande for framstellning av 3-(trisubstituerad bensoyl)-propionsyra

Country Status (14)

Country Link
US (1) US3943169A (sv)
AT (1) AT319216B (sv)
AU (1) AU474825B2 (sv)
BE (1) BE788749A (sv)
CA (1) CA997360A (sv)
CH (2) CH592038A5 (sv)
DE (1) DE2244324C2 (sv)
FR (1) FR2154503B1 (sv)
GB (1) GB1387733A (sv)
MY (1) MY7800304A (sv)
NL (1) NL174547C (sv)
NO (1) NO136492C (sv)
PH (1) PH12087A (sv)
SE (1) SE397974B (sv)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4008323A (en) * 1974-03-25 1977-02-15 Pierre Fabre S.A. Method of reducing cholesterol using certain aromatic keto acids
FR2481118A1 (fr) * 1980-04-24 1981-10-30 Roussel Uclaf Application a titre de medicaments de derives substitues de l'acide phenyl-4-oxo-2-butenoique
FR2481270A1 (fr) * 1980-04-24 1981-10-30 Roussel Uclaf Nouveaux derives substitues de l'acide 4-phenyl 4-oxo 2-hydroxy butanoique, procede pour leur preparation et applications comme medicaments
FR2489313A1 (fr) * 1980-09-04 1982-03-05 Hoechst France Procede de fabrication d'acides hydroxyarylglyoxyliques et de leurs sels alcalins et son application a la fabrication du para-hydroxyphenylglyoxylate de sodium
FR2504004A1 (fr) 1981-04-17 1982-10-22 Roussel Uclaf Application a titre de medicaments de derives d'acides phenyl aliphatique carboxyliques
FR2504127B1 (fr) * 1981-04-17 1985-07-19 Roussel Uclaf Nouveaux derives d'acides phenyl aliphatique carboxyliques, procede pour leur preparation et leur application comme medicaments
GB2108500B (en) * 1981-10-22 1985-05-15 Roussel Uclaf Aminobenzene medicaments
IT1210582B (it) * 1981-10-22 1989-09-14 Roussel Maestretti Spa Derivati di acido 4-fenil-4-ossobuten-2-oico dotati di proprieta'farmacologiche e composizioni farmaceutiche che li contengono
FR2515037A1 (fr) * 1981-10-22 1983-04-29 Roussel Uclaf A titre de medicaments, certains derives mono-substitues de l'acide 4-phenyl 4-oxo buten-2-oique, ainsi que les compositions les renfermant
IL69691A (en) * 1982-09-23 1988-01-31 Merck Frosst Canada Inc Leukotriene antagonists,their preparation and pharmaceutical compositions containing them
US5135940A (en) * 1982-09-23 1992-08-04 Merck Frosst Canada, Inc. Leukotriene antagonists
SE454355B (sv) * 1983-01-24 1988-04-25 Roussel Uclaf Akrylsyraderivat innehallande en furyl-, pyranyl-, bensofuranyl-, oxazolyl- eller isoxazolylgrupp, forfarande for framstellning derav samt farmaceutiska kompositioner innehallande nemnda derivat
IT1169783B (it) * 1983-08-25 1987-06-03 Roussel Maestretti Spa Derivati dell' acido 4-fenil 4-osso-buten 2-oico, loro procedimento di preparazione e loro applicazione come prodotti medicinali
JPS6051168A (ja) * 1983-08-31 1985-03-22 Taisho Pharmaceut Co Ltd ジフェニルスルフィド誘導体
US4544565A (en) * 1984-03-29 1985-10-01 General Foods Corporation Foodstuffs containing sweetness inhibiting agents
US5098613A (en) * 1987-01-12 1992-03-24 Eli Lilly And Company Anti-inflammatory agents
US5294613A (en) * 1987-01-12 1994-03-15 Eli Lilly And Company Method of treating endotoxic shock in mammals
US4945099A (en) * 1987-01-12 1990-07-31 Eli Lilly And Company Anti-inflammatory agents
CA1315279C (en) * 1987-01-12 1993-03-30 Nancy Grace Bollinger Anti-inflammatory agents
CN108069847B (zh) * 2016-11-11 2022-06-17 湖南尔康制药股份有限公司 一种合成曲匹布通的方法
RU2733719C1 (ru) * 2019-04-23 2020-10-06 Общество С Ограниченной Ответственностью "Валента - Интеллект" Комбинация для лечения функциональных заболеваний органов желудочно-кишечного тракта

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2720542A (en) * 1954-08-24 1955-10-11 Merck & Co Inc 1-hydroxy-4-methoxy-7-keto-13-methyl-5, 6, 7, 9, 10, 13-hexahydrophenanthrene and processes of preparing the same
US3515731A (en) * 1966-06-17 1970-06-02 Pfizer & Co C Antibacterial agents
US3502679A (en) * 1967-05-31 1970-03-24 Sandoz Ag 10b-substituted 1,2,3,5,6,10b - hexahydropyrrolo(2,1-a)isoquinolines and process therefor
US3509132A (en) * 1967-07-14 1970-04-28 Sandoz Ag Decahydro-1,6-diazecines

Also Published As

Publication number Publication date
NL174547C (nl) 1984-07-02
AU4640572A (en) 1974-03-14
GB1387733A (en) 1975-03-19
AT319216B (de) 1974-12-10
NL174547B (nl) 1984-02-01
BE788749A (fr) 1973-03-13
NL7212375A (sv) 1973-03-15
NO136492B (sv) 1977-06-06
DE2244324C2 (de) 1986-03-27
FR2154503A1 (sv) 1973-05-11
NO136492C (no) 1977-09-14
CA997360A (en) 1976-09-21
AU474825B2 (en) 1976-08-05
US3943169A (en) 1976-03-09
FR2154503B1 (sv) 1976-03-05
CH592038A5 (sv) 1977-10-14
DE2244324A1 (de) 1973-04-12
PH12087A (en) 1978-10-30
MY7800304A (en) 1978-12-31
CH593900A5 (sv) 1977-12-30

Similar Documents

Publication Publication Date Title
SE397974B (sv) Forfarande for framstellning av 3-(trisubstituerad bensoyl)-propionsyra
SE432102B (sv) Forfarande for framstellning av estrar av penicilliner
SE398229B (sv) Forfarande for framstellning av 4-fenoxi-fenoxialkankarbonsyraderivat
NO145918C (no) Fremgangsmaate for fremstilling av 7-acylamido-3-cefem-4-karboksylsyrer
SE412239B (sv) Forfarande for framstellning av 7-acylamino-cef-3-em-4-karbonsyraforeningar
SE397677B (sv) Forfarande for framstellning av en alfa-dipeptidlagalkylester av l-asparaginsyra
NO144153C (no) Fremgangsmaate for fremstilling av delta3-7-acylamido-3-metyl-cefem-4-karboksylsyrer
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
NO147917C (no) Fremgangsmaate for fremstilling av 3-metyl-delta3-cefem-4-karboksylsyre-forbindelser
SE382809B (sv) Forfarande for framstellning av fenoxiettiksyraderivat
SE396753B (sv) Analogiforfarande for framstellning av en forening tillhorande dihydrolysergsyraserien
SE395455B (sv) Forfarande for framstellning av 3-(fenyl-piperazinyl) etylindoliner
SE400764B (sv) Forfarande for framstellning av substituerade 3-hydroximetylisokinoliner
SE417200B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE395897B (sv) Forfarande for framstellning av 7beta-acylamido-3-metyl-cef-3-em-4-karbonsyror
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
SE392611B (sv) Forfarande for framstellning av antrakinonkarboxylsyra
SE397090B (sv) Forfarande for framstellning av hydroxipyrimidiner
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE419082B (sv) Acyloxialkylkarboxylsyror till anvendning for framstellning av alfa-acyloxialkyl-penicilliner
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE417209B (sv) Forfarande for framstellning av halogenerade fenyltioacetamidocefalosporansyror
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE392724B (sv) Forfarande for framstellning av 7-aminocefalosporansyra